MEREO
Live / Registered — Registered — partial invalidation of extension of protection (as of 05 Feb 2024)
What this means for you
Registered since 30 May 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79189354
- Registration number
- 5211334
- Mark type
- Stylized text
- Filed
- 04 May 2016
- Published for opposition
- 14 Mar 2017
- Registered
- 30 May 2017
- Attorney of record
- Anessa Owen Kramer
Goods and services
- Class 005 — Pharmaceuticals: [ Pharmaceutical and biopharmaceutical preparations and drugs for the treatment of rare and specialist diseases and conditions; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of orphan diseases; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of inflammatory diseases; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of respiratory disorders; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of chronic obstructive pulmonary disease (COPD); pharmaceutical and biopharmaceutical preparations and drugs for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD); pharmaceutical and biopharmaceutical preparations and drugs, namely, bronchodilators and anti-asthma preparations; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of osteogenesis imperfecta (OI) (brittle bone syndrome); pharmaceutical and biopharmaceutical preparations and drugs to improve bone density and treat bone weakness; pharmaceutical and biopharmaceutical preparations and drugs for the treatment of obesity; pharmaceutical and biopharmaceutical preparations and drugs for normalising testosterone levels; pharmaceutical and biopharmaceutical preparations and drugs, namely, aromatase inhibitors (AIs); pharmaceutical and biopharmaceutical preparations and drugs for treating hypogonadotrophic hypogonadism (HH); antibiotics ]
- Class 042 — Scientific and technological services: Scientific research and design relating thereto; industrial analysis and research services in the field of medicine and disease; medical and pharmaceutical research services; scientific research for medical purposes; research, inspection, testing, development and evaluation of the pharmaceutical products of others in the field of medicine and disease; research, inspection, testing, development and evaluation of pharmaceutical [ and veterinary ] preparations, products and drugs; conducting clinical trials for others; information, advisory and consultancy services relating to all the aforesaid services
Owner
- Mereo BioPharma Group Plc, GB
- Mereo BioPharma Group Limited, London W1G 0QF, GB
- Mereo BioPharma Group Limited, London W1G 0QF, GB
Prosecution history
- 19 Feb 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 11 Aug 2025 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 06 Dec 2024 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 29 Nov 2024 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 22 Oct 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 22 Oct 2024 — INVALIDATION PROCESSED
- 06 Oct 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 05 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 05 Feb 2024 — REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
- 29 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 May 2023 — TEAS SECTION 71 & 15 RECEIVED
- 30 May 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 28 Jan 2019 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 17 Jan 2019 — RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
- 28 Oct 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB